Purchase Order HT941024P0187
Award Date
7/11/24
Potential Completion Date
8/15/24
Potential Value
$39K
Federal Agency
Defense Health Agency
Awardee
Biofire Defense LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84107, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Defense Health Agency to Biofire Defense LLC, a manufacturer of biological threat identification products, for the delivery of respiratory panel test kits and blood culture kits to the Naval Medical Center San Diego. The award, valued at $872,184.98, has an ultimate completion date of September 20, 2023. Biofire Defense LLC has a history of prior prime and subcontract awards from various federal agencies, including the Department of...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Biofire Defense LLC, a manufacturer of biological agent identification products. The contract is for the delivery of MOLECULAR DIAGNOSTICS KITS and has a ceiling value of $3,498,082.42 with a period of performance through September 29, 2029. There is no set-aside designation for this contract. Biofire Defense LLC has previously been awarded other prime and subcontract work with the Department of...
This $84,649.21 firm fixed price purchase order was awarded by the Defense Health Agency (DHA) to Biofire Defense LLC, a biodefense and infectious disease diagnostics company, on September 23, 2022. The contract is for the delivery of RP2.1 DE NOVO PANEL KIT 30 TEST products to the U.S. Naval Hospital in Guam, with a completion date of October 20, 2022. This award is not associated with a set-aside program. Biofire Defense has previously received other prime and subcontract awards from DoD...
The Defense Health Agency awarded a $141,750 firm-fixed-price purchase order to Biofire Defense LLC, a for-profit limited liability company and manufacturer of biological agent identification products. The contract is for the delivery of 30 units of the Respiratory Panel 2.1 IVD, a diagnostic product that supports biodefense and infectious disease testing. This award does not have a set-aside designation. Biofire Defense has previously received other federal contracts and grants related to...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Biofire Defense LLC, a for-profit limited liability company, for the delivery of 42 kits of the BioFire Global Fever Panel v2.1 IVD, 2 kits of the BioFire SHIELD Control Kit for the Global Fever Panel, and 3 kits of the Respiratory Panel 2.1 IVD. The total ceiling value of this contract is $90,259.00, with a period of performance ending on August 8, 2022. There was no set-aside...
The Defense Health Agency awarded a $18,752.00 firm fixed price purchase order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for a four-year extended warranty on the FILM ARRAY equipment at Lemoore Naval Air Station in California. This contract does not have a set-aside designation. Biofire Defense has previously received other prime and subcontract awards from the Department of Defense, Department of...
The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the...
This federal contract award to Biofire Defense LLC, a for-profit limited liability company based in Utah, is for the supply of Biofire Film Array reagent kits and equipment maintenance services for the U.S. Naval Hospital in Guam. The $1,588,993.75 firm-fixed-price purchase order was awarded by the Defense Health Agency and has an ultimate completion date of February 9, 2030. The contract includes a base year and four one-year option periods. The original solicitation, RFQ HT941025Q2014,...
The Defense Health Agency (DOD) awarded a $746,778 firm fixed price purchase order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is for the delivery of 184 kits containing 30 tests each of Biofire Defense's RESPIRATORY PANEL 2.1 in vitro diagnostic test panels. The place of performance is Biofire Defense's facility in Salt Lake City and the period of performance runs from June 16, 2022 through September 14, 2022. The contract was awarded under the National Interest Action...
This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company and manufacturer of goods. The $48,748.00 firm fixed price purchase order is for the delivery of a Respiratory Panel 2.1 IVD with 30 tests. The contract has an ultimate completion date of March 11, 2025. Biofire Defense LLC is a provider of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems,...